Détail - canceropole-wordpress

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.

Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J, Narkiewicz K, Sassi-Sayadi M, Wang JG, Weber M, Schlaich M

Hypertension. 2025 12 9;:

Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD.

Witoslawska A, Drechsler C, Duarte K, Girerd N, Zannad F, Rossignol P, Kleber ME, Scharnagl H, Wanner C, März W, Laaksonen R

Clin J Am Soc Nephrol. 2025 12 1;20(12):1683-1695

EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial.

Simon A, Girerd N, Jaisser F, Bozec E, Lepage X, Mercklé L, Rossignol P, Frimat L, Girerd S

Trials. 2025 11 7;26(1):479

Saturated fat from dairy sources and cardio-metabolic health: insights from the STANISLAS cohort.

Wagner S, Girerd N, Lemonnier C, Yena K, Lamiral Z, Duarte K, Merkling T, Merckle L, Bozec E, Dougkas A, Hoge A, Guillaume M, Rossignol P, Nazare JA, Vors C, Boivin JM, Michalski MC

Eur J Nutr. 2025 08 30;64(6):267

Reduction of Antihypertensive Treatment in Nursing Home Residents.

Benetos A, Gautier S, Freminet A, Metz A, Labat C, Georgiopoulos I, Bertin-Hugault F, Beuscart JB, Hanon O, Karcher P, Manckoundia P, Novella JL, Diallo A, Vicaut E, Rossignol P,

N Engl J Med. 2025 08 29;:

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials.

Pyne L, Rossignol P, Giles C, Junek M, Mark PB, Gallagher M, de Zoysa JR, Devereaux PJ, Walsh M

Lancet. 2025 08 23;406(10505):811-820

Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: The STOP-Trial.

Boivin JM, Ferreira JP, Lopez-Sublet M, Duarte K, Zannad F, Rossignol P, Girerd N

Eur J Prev Cardiol. 2025 08 21;:

Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.

Rossignol P, Zannad F, Massy Z, Azizi M, Chorfa F, Coadic J, Ferreira JP, Saraiva F, Mottier D, Guillemin F, Ngueyon Sime W, Bouali S, Rossignol B, Nortier J, Simon I, Robino C, Davin M, Bataille PM, Chantrel F, Castin N, Esnault V, Kazes I, Hannedouche T, Kamar N, Achard JM, Fenerol C, Achard-Hottelart C, Dimitrov Y, Girerd N, Maucourt-Boulch D, Frimat L,

Lancet. 2025 08 16;406(10504):705-718

Expert Perspectives on Incorporating GLP-1 RA in Diabetes and Chronic Kidney Disease - Challenges and Opportunities.

Halimi JM, Fauchier L, Karras A, Amouyal C, Eladari D, Rossignol P, Choukroun G, Zaoui P, Girerd N, Hadjadj S

Eur J Prev Cardiol. 2025 07 15;:

Plasma myeloperoxidase and echocardiographic markers of impaired diastolic function in healthy individuals.

Wang N, Xhaard C, Baudry G, Monzo L, Bozec E, Duarte K, Rossignol P, Zannad F, Lund L, Girerd N

Heart. 2025 07 11;:

Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study.

Kalogeropoulos AP, Hameed I, Anker SD, Bayes-Genis A, Böhm M, Budden J, Cleland JGF, Coats AJS, Ezekowitz JA, Filippatos G, Goudev A, Khan MS, Lindenfeld J, Lund LH, Merkely B, Mentz RJ, Metra M, Moutchia J, Perrin A, Ponikowski P, Priest EL, Rossignol P, Senni M, Shaver C, Waechter S, Weir MR, Pitt B, Butler J

Eur J Heart Fail. 2025 07 3;:

Study protocol and statistical plan for the ICRAKI trial: Intermittent haemodialysis versus continuous renal replacement therapy for severe acute kidney injury in critically ill patients.

Gaudry S, Boubaya M, Louis G, Chaïbi K, Mégarbane B, Bohe J, Desgrouas M, Gele-Decaudin G, Joseph A, de Montmollin E, Camus C, De Prost N, Bailly P, Jaber S, Chudeau N, Lambour A, Robine A, La Combe B, Kimmoun A, Chevrel G, Argaud L, Nicolas J, Thiery G, Faguer S, Jozwiak M, Ricard JD, Contou D, Marzouk M, Chousterman B, Cadiet J, Bureau C, Zaleski ID, Rossignol P, Quenot JP, Queyrat CB, Dreyfuss D

Crit Care Resusc. 2025 06;27(2):100107

Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease.

Bozkurt B, Rossignol P, Vassalotti JA

Eur J Heart Fail. 2025 05 27;:

Higher Risk of Kidney Failure Associated with Angiotensin Receptor Blockers Versus ACE Inhibitors in Patients with Heart Failure.

Moore HJ, Wu WC, Heidenreich PA, Rossignol P, Patel SS, Lu F, Lam PH, Ahmed AA, Faselis C, Butler J, Palant CE, Pitt B, Weir MR, Deedwania P, Atkins D, Raman VK, Rangaswami J, Vargas JD, Zhang S, Morgan CJ, Sheriff HM, Zeng-Treitler Q, Fonarow GC, Ahmed A

Am J Med. 2025 05 24;:

Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease.

Kobayashi M, Pitt B, Ferreira JP, Rossignol P, Girerd N, Zannad F

Eur Heart J. 2025 04 11;:

Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients.

Tydén M, Westerlund ME, Duarte K, Eriksson N, Girerd N, Krämer BK, März W, Rossignol P, Scharnagl H, Soveri I, Svensson MK, Zannad F, Fellström B

Clin Kidney J. 2025 04;18(4):sfaf047

Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial.

Monzo L, Kobayashi M, Ferreira JP, Lamiral Z, Delles C, Clark AL, Edelmann F, González A, Heymans S, Pellicori P, Petutschnigg J, Verdonschot JAJ, Rossignol P, Cleland JGF, Zannad F, Girerd N,

Cardiovasc Diabetol. 2025 03 8;24(1):111

Cross-sectional associations between healthy and unhealthy plant-based diets and metabolic syndrome in three distinct French populations, a meta-analysis.

Prioux C, Wagner S, Fézeu LK, Deschamps V, Verdot C, Baudry J, Touvier M, Herberg S, Nazare JA, Hoge A, Ferreira JP, Rossignol P, Girerd N, Tatulashvili S, Kesse-Guyot E, Allès B

Br J Nutr. 2025 03 3;:1-48

Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort.

Xia LLCH, Girerd N, Lamiral Z, Duarte K, Merckle L, Leroy C, Nazare JA, Van Den Berghe L, Seconda L, Hoge A, Guillaume M, Laville M, Rossignol P, Boivin JM, Wagner S

Eur J Nutr. 2025 02 17;64(2):94

Sodium zirconium cyclosilicate for MRAs optimization in HFrEF: lessons learned from the REALIZE-K trial.

Monzo L, Musella F, Girerd N, Rossignol P

Heart Fail Rev. 2025 01 30;:

Circulating growth differentiation factor-15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20-year follow-up study.

Monzo L, Xhaard C, Ferreira JP, Baudry G, Lamiral Z, Duarte K, Bozec E, Boivin JM, Huttin O, Rossignol P, Zannad F, Girerd N

Eur J Heart Fail. 2025 01 21;:

Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.

Witoslawska A, Meessen JMTA, Hilvo M, Jylhä A, Zannad F, Cerrato M, Rossignol P, Novelli D, Duarte K, Targher G, Latini R, Girerd N, Laaksonen R

Eur J Clin Invest. 2024 11 23;:e14359

Bladder Symptoms Prvoked by Short, Rapid Acting Loop Diuretics: A Frequent But Often Overlooked Problem.

Wilcox CS, Pourafshar N, Han K, Shah S, Sussman RD, Testani J, Packer M, Rossignol P, Zannad F, Pitt B, Shah S

Am J Hypertens. 2024 11 1;:

Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.

Dieden A, Girerd N, Ottosson F, Molvin J, Pareek M, Melander O, Bachus E, Råstam L, Lindblad U, Daka B, Leósdóttir M, Nilsson PM, Olsen MH, Clark AL, Cleland JGF, Delles C, González A, Lamiral Z, Duarte K, Rossignol P, Zannad F, Gudmundsson P, Jujić A, Magnusson M

Eur J Heart Fail. 2024 10 28;:

Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia.

Pitt B, Anker SD, Lund LH, Coats AJS, Filippatos G, Rossignol P, Weir MR, Friede T, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Piña IL, Pinto FJ, van der Meer P, Bahit C, Belohlavek J, Brugts JJ, Perrin A, Waechter S, Budden J, Butler J

J Am Coll Cardiol. 2024 10 1;84(14):1295-1308

Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.

Coats AJS, Anker SD, Lund LH, Filippatos G, Rossignol P, Pitt B, Weir MR, Kosiborod MN, Metra M, Böhm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Cleland JGF, Goudev A, Khintibidze I, Lindenfeld J, Merkely B, Waechter S, Budden J, Perrin A, Butler J

JACC Heart Fail. 2024 09 12;:

Where Are Patients' Voices in Chronic Kidney Disease?

Rüssmann D, Roy-Chaudhury P, Chertow GM, Gee P, Chauhan C, Macari S, Murphy M, Rossignol P

Clin J Am Soc Nephrol. 2024 08 30;:

Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohort.

Holm H, Magnusson M, Jujić A, Lagrange J, Bozec E, Lamiral Z, Bresso E, Huttin O, Baudry G, Monzo L, Rossignol P, Zannad F, Girerd N

Eur J Heart Fail. 2024 08 27;:

Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.

Weir MR, Rossignol P, Pitt B, Lund LH, Coats AJS, Filippatos G, Perrin A, Waechter S, Budden J, Kosiborod M, Metra M, Boehm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Castro-Montes E, Nicolau JC, Parkhomenko A, Seferovic P, Cohen-Solal A, Anker SD, Butler J

Am J Nephrol. 2024 08 19;:

Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up.

Dupont V, Xhaard C, Behm-Ansmant I, Bresso E, Thuillier Q, Branlant C, Lopez-Sublet M, Deleuze JF, Zannad F, Girerd N, Rossignol P

Clin Kidney J. 2024 08;17(8):sfae224

Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.

Collister D, Pyne L, Bhasin AA, Smyth B, Herrington W, Jardine M, Mark PB, Badve S, Rossignol P, Dember LM, Wanner C, Ezekowitz J, Devereaux PJ, Parfrey P, Gansevoort R, Walsh M

Nephrol Dial Transplant. 2024 07 10;:

When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failure.

Pitt B, Rossignol P

Eur J Heart Fail. 2024 06 10;:

Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment.

Leierer J, Salib M, Evgeniou M, Rossignol P, Massy ZA, Kratochwill K, Mayer G, Fellström B, Girerd N, Zannad F, Perco P

Heliyon. 2024 05 15;10(9):e30709

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.

Yu YL, Siwy J, An DW, González A, Hansen T, Latosinska A, Pellicori P, Ravassa S, Mariottoni B, Verdonschot JA, Ahmed F, Petutschnigg J, Rossignol P, Heymans S, Cuthbert JJ, Girerd N, Clark AL, Verhamme P, Nawrot TS, Janssens S, Cleland JG, Zannad F, Diez J, Mischak H, Ferreira JP, Staessen JA,

Heart. 2024 05 9;:

Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.

Kobayashi M, Ferreira JP, Kevin D, Bresso E, Huttin O, Bozec E, Brunner La Rocca HP, Delles C, Clark AL, Edelmann F, González A, Heymans S, Pellicori P, Petutschnigg J, Verdonschot JAJ, Rossignol P, Cleland JGF, Zannad F, Girerd N,

Eur J Heart Fail. 2024 03 25;:

Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials.

Legrand M, Bagshaw SM, Bhatraju PK, Bihorac A, Caniglia E, Khanna AK, Kellum JA, Koyner J, Harhay MO, Zampieri FG, Zarbock A, Chung K, Liu K, Mehta R, Pickkers P, Ryan A, Bernholz J, Dember L, Gallagher M, Rossignol P, Ostermann M

Crit Care. 2024 03 21;28(1):92

Dietary inflammatory potential and arterial stiffness in a French cohort: Insights from the STANISLAS study.

Agbo LD, Girerd N, Lamiral Z, Duarte K, Bozec E, Merckle L, Hoge A, Guillaume M, Laville M, Nazare JA, Rossignol P, Boivin JM, Wagner S

Nutr Metab Cardiovasc Dis. 2024 03 20;:

Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers, and health professionals.

Matus Gonzalez A, Evangelidis N, Howell M, Jaure A, Sautenet B, Madero M, Ashuntantang G, Anumudu S, Bernier-Jean A, Dunn L, Cho Y, Cortes Sanabria L, de Boer IH, Fung S, Gallego D, Guha C, Levey AS, Levin A, Lorca E, Okpechi IG, Rossignol P, Scholes-Robertson N, Sola L, Teixeira-Pinto A, Usherwood T, Viecelli AK, Wheeler DC, Widders K, Wilkie M, Craig JC,

Nephrol Dial Transplant. 2024 01 17;:

Chronic cardiovascular-kidney disorder: a new conceptual framework.

Zoccali C, Mallamaci F, Halimi JM, Rossignol P, Serafidis P, De Caterina R, Giugliano R, Zannad F

Nat Rev Nephrol. 2023 11 15;:

Impact of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort.

Pinter J, Smyth B, Stuard S, Jardine M, Wanner C, Rossignol P, Wheeler DC, Marshall MR, Canaud B, Genser B

J Am Soc Nephrol. 2023 11 15;:

Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.

Santos-Ferreira D, Diaz SO, Ferreira JP, Girerd N, Pellicori P, Mariottoni B, Cosmi F, Hazebroek M, Verdonschot JAJ, Cuthbert J, Petutschnigg J, Heymans S, Staessen JA, Pieske B, Edelmann F, Clark AL, Rossignol P, Fontes-Carvalho R, Cleland JGF, Zannad F

ESC Heart Fail. 2023 11 8;:

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA).

Sarafidis P, Iatridi F, Ferro C, Alexandrou ME, Fernandez-Fernandez B, Kanbay M, Mallamaci F, Nistor I, Rossignol P, Wanner C, Cozzolino M, Ortiz A

Clin Kidney J. 2023 11;16(11):1885-1907

From Cardio Renal Syndrome to Chronic Cardiovascular and Kidney Disorder: A Conceptual Transition.

Zoccali C, Mallamaci F, Halimi M, Rossignol P, Serafidis P, De Caterina R, Giugliano R, Zannad F

Clin J Am Soc Nephrol. 2023 10 30;:

Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure Registry.

Girerd N, Coiro S, Benson L, Savarese G, Dahlström U, Rossignol P, Lund LH

Eur J Heart Fail. 2023 10 26;:

Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations.

Hannedouche T, Rossignol P, Darmon P, Halimi JM, Vuattoux P, Hagege A, Videloup L, Guinard F

Postgrad Med. 2023 09 21;:1-13

Role of aldosterone in the mid- and long-term left ventricular remodelling after acute myocardial infarction: the REMI study.

Monzo L, Huttin O, Ferreira JP, Lamiral Z, Bozec E, Beaumont M, Micard E, Baudry G, Marie PY, Eschalier R, Rossignol P, Zannad F, Girerd N

Eur J Heart Fail. 2023 08 2;:

Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: !

Rossignol P, Pitt B

Clin Kidney J. 2023 08;16(8):1221-1225

Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients.

Brandão M, Fonseca T, Quelhas Costa R, Oliveira JC, Cyrne Carvalho H, Rodrigues P, Zannad F, Rossignol P, Ferreira MB, Ferreira JP

Clin Exp Rheumatol. 2023 07 13;:

NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance.

Bonnard B, El Moghrabi S, Ueda K, Lattenist L, Soulie M, López-Andrés N, Xhaard C, Shimosawa T, Rossignol P, Jaisser F

Hypertension. 2023 06 28;:

Layer myocardial strain is the most heritable echocardiographic trait.

Huttin O, Xhaard C, Dandine-Roulland C, Le Floch E, Bacq-Daian D, Lamiral Z, Bozec E, Deleuze JF, Zannad F, Rossignol P, Girerd N

Eur Heart J Cardiovasc Imaging. 2023 06 23;:

Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective.

de Pouvourville G, Rossignol P, Boussahoua M, Chevalier J, Gabb PD, Poulnais R, Verboux D, Rao N, Sörstadius E, Garcia Sanchez JJ

Adv Ther. 2023 06 21;:

Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, rando

Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S,

EClinicalMedicine. 2023 06;60:102031

SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.

Mark PB, Sarafidis P, Ekart R, Ferro CJ, Balafa O, Fernandez-Fernandez B, Herrington WG, Rossignol P, Del Vecchio L, Valdivielso JM, Mallamaci F, Ortiz A, Nistor I, Cozzolino M,

Nephrol Dial Transplant. 2023 05 25;:

Shared Heritability of Blood Pressure and Pulse Wave Velocity: Insights From the STANISLAS Cohort.

Xhaard C, de Villemereuil P, Benetos A, Bozec E, Dandine-Roulland C, Le Floch E, Regnault V, Lacolley P, Zannad F, Rossignol P, Girerd N

Hypertension. 2023 05 11;:

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.

Girerd N, Levy D, Duarte K, Ferreira JP, Ballantyne C, Collier T, Pizard A, Björkman J, Butler J, Clark A, Cleland JG, Delles C, Diez J, González A, Hazebroek M, Ho J, Huby AC, Hwang SJ, Latini R, Mariottoni B, Mebazaa A, Pellicori P, Sattar N, Sever P, Staessen JA, Verdonschot J, Heymans S, Rossignol P, Zannad F

Circ Heart Fail. 2023 05;16(5):e009694

Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation.

Salib M, Girerd N, Simon A, Kearney-Schwartz A, Duarte K, Leroy C, Rossignol P, Benetos A, Frimat L, Girerd S

Ann Transplant. 2023 04 25;28:e938137

Ventricular-arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort.

Holm H, Magnusson M, Jujić A, Pugliese NR, Bozec E, Lamiral Z, Huttin O, Zannad F, Rossignol P, Girerd N

Atherosclerosis. 2023 04 22;374:11-20

Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures.

Ferreira MB, Kobayashi M, Costa RQ, Fonseca T, Brandão M, Oliveira JC, Marinho A, Cyrne Carvalho H, Rodrigues P, Zannad F, Rossignol P, Barros AS, Ferreira JP

Scand J Rheumatol. 2023 04 21;:1-8

Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study).

Lopez-Sublet M, Merkling T, Girerd N, Xhaard C, Flahault A, Bozec E, Leroy C, Fujikawa T, Vaag AA, Mebazaa A, Kistorp CM, Heude B, Boivin JM, Zannad F, Wagner S, Rossignol P

J Hypertens. 2023 04 18;:

A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial.

Kobayashi M, Huttin O, Ferreira JP, Duarte K, González A, Heymans S, Verdonschot JAJ, Rocca HB, Pellicori P, Clark AL, Petutschnigg J, Edelmann F, Cleland JG, Rossignol P, Zannad F, Girerd N,

Eur J Heart Fail. 2023 04 16;:

Defining Myocardial Infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.

O'Lone E, Apple FS, Burton JO, Caskey FJ, Craig JC, de Filippi CR, Forfang D, Hicks KA, Jha V, Mahaffey KW, Mark PB, Rossignol P, Scholes-Robertson N, Jaure A, Viecelli AK, Wang AY, Wheeler DC, White D, Winkelmayer WC, Herzog CA

Kidney Int. 2023 04 4;:

Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.

Patel S, Lam PH, Kanonidis E, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A

Am J Med. 2023 04 3;:

Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial.

H Brandt-Jacobsen N, Johansen ML, Rasmussen JJ, Dalsgaard M, Kumler T, Faber J, Rossignol P, Schou M, Kistorp C

BMC Cardiovasc Disord. 2023 03 31;23(1):175

Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?

Rossignol P, Pitt B

Eur J Heart Fail. 2023 02 16;:

Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.

Ferreira JP, Cleland JG, Girerd N, Rossignol P, Pellicori P, Cosmi F, Mariottoni B, González A, Diez J, Solomon SD, Claggett B, Pfeffer MA, Pitt B, Petutschnigg J, Pieske B, Edelmann F, Zannad F

Int J Cardiol. 2023 02 2;:

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.

Agarwal R, Pitt B, Palmer BF, Kovesdy CP, Burgess E, Filippatos G, Małyszko J, Ruilope LM, Rossignol P, Rossing P, Pecoits-Filho R, Anker SD, Joseph A, Lawatscheck R, Wilson D, Gebel M, Bakris GL

Clin Kidney J. 2023 02;16(2):293-302

Association between eating behaviour and 13-year cardiovascular damages in the initially healthy STANISLAS cohort.

Puchkova-Sistac A, de Lauzon-Guillain B, Girerd N, Boivin JM, Bozec E, Mercklé L, Nazare JA, Laville M, Rossignol P, Wagner S

Eur J Prev Cardiol. 2023 01 11;:

Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial).

Ferreira JP, Cleland JGF, Girerd N, Pellicori P, Hazebroek MR, Verdonschot J, Collier TJ, Petutschnigg J, Clark AL, Staessen JA, Heymans S, Rossignol P, Zannad F

Am J Cardiol. 2023 01 10;191:39-42

Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review.

Wilson GJ, Van K, O'Lone E, Tong A, Craig JC, Sautenet B, Budde K, Forfang D, Gill J, Herrington WG, Jafar TH, Johnson DW, Krane V, Levin A, Malyszko J, Rossignol P, Sawinski D, Scholes-Robertons N, Strippoli G, Wang A, Winkelmayer WC, Hawley CM, Viecelli AK

Transplant Direct. 2023 01;9(1):e1398

Associations of childhood adiposity with adult intima-media thickness and inflammation: a 20-year longitudinal population-based cohort.

Fujikawa T, Kobayashi M, Wagner S, Duarte K, Scherdel P, Heude B, Dupontd V, Bozec E, Bresso E, Zannad F, Rossignol P, Girerd N

J Hypertens. 2022 12 23;:

Hypertension management in patients with cardiovascular comorbidities.

Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, Townsend RR, Tsioufis C, Weber MA, Weber T, Böhm M

Eur Heart J. 2022 11 7;:

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.

Rossignol P, Duarte K, Bresso E, A Å, Devignes MD, Eriksson N, Girerd N, Glerup R, Jardine AG, Holdaas H, Lamiral Z, Leroy C, Massy Z, März W, Krämer B, Wu PH, Schmieder R, Soveri I, Christensen JH, Svensson M, Zannad F, Fellström B

Eur Heart J Open. 2022 11;2(6):oeac069

Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs.

Ferreira JP, Pitt B, McMurray JJV, Pocock SJ, Solomon SD, Pfeffer MA, Zannad F, Rossignol P

JACC Heart Fail. 2022 11;10(11):842-850

Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.

Ferreira JP, Cleland JG, Girerd N, Bozec E, Rossignol P, Pellicori P, Cosmi F, Mariottoni B, Solomon SD, Pitt B, Pfeffer MA, Shah AM, Petutschnigg J, Pieske B, Edelmann F, Zannad F

Eur J Heart Fail. 2022 10 27;:

Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial.

Ferreira JP, Cleland JGF, Girerd N, Pellicori P, Hazebroek MR, Verdonschot J, Collier TJ, Petutschnigg J, Clark AL, Staessen JA, Heymans S, Zannad F, Rossignol P

Clin Res Cardiol. 2022 10 24;:

High versus low dose losartan and serum potassium: an analysis from HEAAL.

Ferreira JP, Konstam M, Rossignol P, Kiernan MS, Zannad F

J Card Fail. 2022 10 13;:

Inductive database to support iterative data mining: Application to biomarker analysis on patient data in the Fight-HF project.

Bresso E, Ferreira JP, Girerd N, Kobayashi M, Preud'homme G, Rossignol P, Zannad F, Devignes MD, Smaïl-Tabbone M

J Biomed Inform. 2022 09 28;:104212

Potassium management with finerenone: Practical aspects.

Wanner C, Fioretto P, Kovesdy CP, Malyszko J, Pecoits-Filho R, Schnell O, Rossignol P

Endocrinol Diabetes Metab. 2022 09 15;5(6):e360

A review from the Biomarkers Working Group of the Heart Failure Association of the ESC: A review from the Biomarkers Working Group of the Heart Failure Association of the ESC.

Bayes-Genis A, Aimo A, Jhund P, Richards AM, de Boer RA, Arfsten H, Fabiani I, Lupón J, Anker SD, González A, Castiglione V, Metra M, Mueller C, Núñez J, Rossignol P, Barison A, Butler J, Teerlink J, Filippatos G, Ponikowski P, Vergaro G, Zannad F, Seferovic P, Rosano G, Coats AJ, Emdin M, Januzzi JL

Eur J Heart Fail. 2022 09 8;:

Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.

Monzo L, Ferreira JP, Cleland JGF, Pellicori P, Mariottoni B, Hazebroek MR, Collier TJ, Cuthbert JJ, Pieske B, Petutschnigg J, Ahmed FZ, Girerd N, Clark AL, Cosmi F, Staessen JA, Heymans S, Rossignol P, Zannad F

ESC Heart Fail. 2022 09 6;:

Congestion in Heart Failure: a circulating biomarker-based perspective.

Núñez J, de la Espriella R, Rossignol P, Voors AA, Mullens W, Metra M, Chioncel O, Januzzi JL, Mueller C, Richards AM, de Boer RA, Thum T, Arfsten H, González A, Abdelhamid M, Adamopoulos S, Anker SD, Gal TB, Biegus J, Cohen-Solal A, Böhm M, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Jhund PS, Lopatin Y, Lund LH, Milicic D, Moura B, Piepoli MF, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJ, Bayes-Genis A

Eur J Heart Fail. 2022 08 30;:

Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction.

Coiro S, Huttin O, Kobayashi M, Lamiral Z, Simonovic D, Zannad F, Rossignol P, Girerd N

Heart Fail Rev. 2022 08 30;:

Timing of Statistical Benefit of Mineralocorticoid Receptor Antagonists Among Patients With Heart Failure and Post-Myocardial Infarction.

Bedrouni W, Sharma A, Pitt B, Lam CSP, Ni J, Ferreira JP, McMurray J, Giannetti N, Girerd N, Rossignol P, Solomon SD, Claggett B, Pocock S, Huynh T, Zannad F

Circ Heart Fail. 2022 08 4;:101161CIRCHEARTFAILURE121009295

Handgrip strength to screen early-onset sarcopenia in heart failure.

Blanquet M, Massoulié G, Boirie Y, Guiguet-Auclair C, Mulliez A, Anker S, Boiteux MD, Jean F, Combaret N, Souteyrand G, Riocreux C, Pereira B, Motreff P, Rossignol P, Clerfond G, Eschalier R

Clin Nutr ESPEN. 2022 08;50:183-190

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.

Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, Friede T, Fabien V, Kosiborod M, Metra M, Piña IL, Pinto F, Rossignol P, van der Meer P, Bahit C, Belohlavek J, Böhm M, Brugts JJ, Cleland JG, Ezekowitz J, Bayes-Genis A, Gotsman I, Goudev A, Khintibidze I, Lindenfeld J, Mentz RJ, Merkely B, Montes EC, Mullens W, Nicolau JC, Parkhomenko A, Ponikowski P, Seferovic PM, Senni M, Shlyakhto E, Cohen-Solal A, Szecsödy P, Jensen K, Dorigotti F, Weir MR, Pitt B

Eur Heart J. 2022 07 28;:

Effects of Steroidal Mineralocorticoid Receptor Antagonists on Acute and Chronic Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Heart Failure.

Vaduganathan M, Ferreira JP, Rossignol P, Neuen B, Claggett BL, Pfeffer MA, McMurray JJV, Pitt B, Zannad F, Solomon SD

Eur J Heart Fail. 2022 07 22;:

Optimizing the Design and Analysis of Future AKI Trials.

Legrand M, Bagshaw SM, Koyner JL, Schulman IH, Mathis MR, Bernholz J, Coca S, Gallagher M, Gaudry S, Liu KD, Mehta RL, Pirracchio R, Ryan A, Steubl D, Stockbridge N, Erlandsson F, Turan A, Wilson FP, Zarbock A, Bokoch MP, Casey JD, Rossignol P, Harhay MO

J Am Soc Nephrol. 2022 07 13;:

Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation.

Baudry G, Coutance G, Dorent R, Bauer F, Blanchart K, Boignard A, Chabanne C, Delmas C, D'Ostrevy N, Epailly E, Gariboldi V, Gaudard P, Goéminne C, Grosjean S, Guihaire J, Guillemain R, Mattei M, Nubret K, Pattier S, Pozzi M, Rossignol P, Vermes E, Sebbag L, Girerd N

ESC Heart Fail. 2022 07 7;:

The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease.

Barrera-Chimal J, Gerarduzzi C, Rossignol P, Jaisser F

Clin Sci (Lond). 2022 06 30;136(12):1005-1017

[Current status of persistent chronic hyperkalaemia in France: An expert consensus based on a Delphi approach].

Rossignol P, Moulin B, Halimi JM, Bataille P, Juillard L, Thervet É, Choukroun G

Nephrol Ther. 2022 06 30;:

Prognosis of Advanced Heart Failure Patients according to Their Hemodynamic Profile Based on the Modified Forrester Classification.

Baudry G, Bourdin J, Mocan R, Hugon-Vallet E, Pozzi M, Jobbé-Duval A, Paulo N, Rossignol P, Sebbag L, Girerd N

J Clin Med. 2022 06 24;11(13):

Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study.

Legrand M, Fong N, Laouénan C, Ghosn J, Thill B, Faure K, Garot D, Goujard C, Curlier E, Resche-Rigon M, Rossignol P, Pirracchio R

BMJ Med. 2022 06 17;1(1):e000093

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease.

Rossignol P, Silva-Cardoso J, Kosiborod MN, Brandenburg V, Cleland JG, Hadimeri H, Hullin R, Makela S, Mörtl D, Paoletti E, Pollock C, Vogt L, Jadoul M, Butler J

Pharmacol Res. 2022 06 1;182:106277

High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study.

Silbernagel G, Duarte K, Sadiku S, Fauler G, März W, Schmieder RE, Jardine AG, Massy ZA, Girerd N, Fellström B, Rossignol P, Scharnagl H, Zannad F

Eur J Prev Cardiol. 2022 May 4;:

Cardiac Remodelling Part 2: Clinical, Imaging and Laboratory Findings A review from the Biomarkers Working Group of the Heart Failure Association of the ESC.

Aimo A, Vergaro G, González A, Barison A, Lupón J, Delgado V, Richards AM, de Boer RA, Thum T, Arfsten H, Hülsmann M, Falcao-Pires I, Díez J, Foo RS, Chan MYY, Anene-Nzelu GC, Abdelhamid M, Adamopoulos S, Anker SD, Belenkov Y, Gal TB, Cohen-Solal A, Böhm M, Chioncel O, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Januzzi JL, Jhund P, Lopatin Y, Lund LH, Metra M, Milicic D, Moura B, Mueller C, Mullens W, Núñez J, Piepoli MF, Rakisheva A, Ristic A, Rossignol P, Savarese G, Tocchetti CG, van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJ, Emdin M, Bayes-Genis A

Eur J Heart Fail. 2022 Apr 30;:

Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up.

Kanbay M, Xhaard C, Le Floch E, Dandine-Roulland C, Girerd N, Ferreira JP, Boivin JM, Wagner S, Bacq-Daian D, Deleuze JF, Zannad F, Rossignol P

J Am Heart Assoc. 2022 Apr 26;:e023301

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.

Wainstein M, MacDonald S, Fryer D, Young K, Balan V, Begum H, Burrell A, Citarella BW, Cobb JP, Kelly S, Kennon K, Lee J, Merson L, Murthy S, Nichol A, Semple MG, Strudwick S, Webb SA, Rossignol P, Claure-Del Granado R, Shrapnel S,

PLoS Med. 2022 Apr 20;19(4):e1003969

Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study.

Ferreira MB, Fonseca T, Costa R, Marinho A, Oliveira JC, Zannad F, Rossignol P, Rodrigues P, Barros AS, Ferreira JP

Int J Rheum Dis. 2022 Apr 15;:

Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.

Girerd N, Von Hunolstein JJ, Pellicori P, Bayés-Genís A, Jaarsma T, Lund LH, Bilbault P, Boivin JM, Chouihed T, Costa J, Eicher JC, Fall E, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Zannad N, Rossignol P, Seronde MF,

ESC Heart Fail. 2022 Apr 15;:

Practical outpatient management of worsening chronic heart failure.

Girerd N, Mewton N, Tartière JM, Guijarro D, Jourdain P, Damy T, Lamblin N, Bayes-Génis A, Pellicori P, Januzzi J, Rossignol P, Roubille F

Eur J Heart Fail. 2022 Apr 13;:

Comparing and contrasting risk factors for Heart failure in patients with and without history of myocardial infarction: Data from HOMAGE and the UK Biobank.

Rastogi T, Ho FK, Rossignol P, Merkling T, Butler J, Clark A, Collier T, Delles C, Jukema JW, Heymans S, Latini R, Mebazaa A, Pellicori P, Sever P, Staessen JA, Thijs L, Cleland JG, Sattar N, Zannad F, Girerd N

Eur J Heart Fail. 2022 Apr 1;:

Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk.

Ferreira JP, Zannad F, Solomon SD, Pitt B, Rossignol P

Clin Kidney J. 2022 Apr;15(4):822-824

Cardiac Remodelling Part 1: From Cells and Tissues to Circulating Biomarkers.

González A, Richards AM, de Boer RA, Thum T, Arfsten H, Hülsmann M, Falcao-Pires I, Díez J, Foo RS, Chan MYY, Aimo A, Anene-Nzelu GC, Abdelhamid M, Adamopoulos S, Anker SD, Belenkov Y, Gal TB, Cohen-Solal A, Böhm M, Chioncel O, Delgado V, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Januzzi JL, Jhund PS, Lopatin Y, Lund LH, Metra M, Milicic D, Moura B, Mueller C, Mullens W, Núñez J, Piepoli MF, Rakisheva A, Ristic A, Rossignol P, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJ, Bayes-Genis A

Eur J Heart Fail. 2022 Mar 25;:

Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD.

Ferreira JP, Vasques-Nóvoa F, Ferrão D, Saraiva F, Falcão-Pires I, Neves JS, Sharma A, Rossignol P, Zannad F, Leite-Moreira A

Diabetes Care. 2022 Mar 23;:

Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study.

Salib M, Simon A, Girerd N, Kearney-Schwartz A, Rossignol P, Benetos A, Frimat L, Girerd S

J Clin Med. 2022 Mar 4;11(5):

Renal effects of guideline directed medical therapies in heart failure - a consensus document from the Heart Failure Association of the European Society of Cardiology.

Mullens W, Martens P, Testani JM, Tang WHW, Skouri H, Verbrugge FH, Fudim M, Iacoviello M, Franke J, Flammer AJ, Palazzuoli A, Barragan PM, Thum T, Marcos MC, Miró Ò, Rossignol P, Metra M, Lassus J, Orso F, Jankowska EA, Chioncel O, Milicic D, Hill L, Seferovic P, Rosano G, Coats A, Damman K

Eur J Heart Fail. 2022 Mar 3;:

Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients.

Massy Z, Merkling T, Wagner S, Girerd N, Essig M, Wanner C, Fellstrom B, Rossignol P, Zannad F

Clin J Am Soc Nephrol. 2022 Mar 2;:

Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness.

Bäck M, Xhaard C, Rouget R, Thuillier Q, Plunde O, Larsson SC, Girerd N, Ferreira JP, Boivin JM, Bozec E, Mercklé L, Zannad F, Hoge A, Guillaume M, Dandine-Roulland C, Floch EL, Bacq-Daian D, Deleuze JF, Van den Berghe L, Nazare JA, Laville M, Branlant C, Behm-Ansmant I, Wagner S, Rossignol P

Eur Heart J Open. 2022 03;2(2):oeac016

Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort.

Rastogi T, Girerd N, Lamiral Z, Bresso E, Bozec E, Boivin JM, Rossignol P, Zannad F, Ferreira JP

Atherosclerosis. 2022 Feb 23;346:1-9

Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.

Ferreira JP, Verdonschot JAJ, Girerd N, Bozec E, Pellicori P, Collier T, Mariottoni B, Cosmi F, Hazebroek M, Cuthbert J, Petutschnigg J, Heymans S, Staessen JA, Pieske B, Edelman F, Clark AL, Díez J, González A, Rossignol P, Cleland JG, Zannad F

Eur J Heart Fail. 2022 Feb 23;:

Metabolic syndrome and the risk of preclinical heart failure: Insights after 17 years of follow-up from the STANISLAS Cohort.

Sharma A, Razaghizad A, Ferreira JP, Machu JL, Bozec E, Girerd N, Rossignol P, Zannad F

Cardiology. 2022 Feb 23;:

The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction.

Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N

J Womens Health (Larchmt). 2022 Jan 18;:

Overcoming barriers in the design and implementation of clinical trials for Acute Kidney Injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.

Lazzareschi D, Mehta RL, Dember LM, Bernholz J, Turan A, Sharma A, Kheterpal S, Parikh CR, Ali O, Schulman IH, Ryan A, Feng J, Simon N, Pirracchio R, Rossignol P, Legrand M

Nephrol Dial Transplant. 2022 Jan 12;:

Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis.

Pisano A, Mallamaci F, D'Arrigo G, Bolignano D, Wuerzner G, Ortiz A, Burnier M, Kanaan N, Sarafidis P, Persu A, Ferro CJ, Loutradis C, Boletis IN, London G, Halimi JM, Sautenet B, Rossignol P, Vogt L, Zoccali C

Clin Kidney J. 2022 Jan;15(1):31-42

Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: A nationwide study in Denmark from 2003-2017.

Zahir D, Bonde A, Madelaire C, Malmborg M, Butt JH, Fosbol E, Gislason G, Torp-Pedersen C, Andersson C, Rossignol P, McMurray JJV, Kober L, Schou M

Eur J Heart Fail. 2021 Dec 30;:

The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial.

Verdonschot JAJ, Ferreira JP, Pizard A, Pellicori P, La Rocca HB, Clark AL, Cosmi F, Cuthbert J, Girerd N, Waring OJ, Henkens MHTM, Mariottoni B, Petutschnigg J, Rossignol P, Hazebroek MR, Cleland JGF, Zannad F, Heymans SRB,

J Card Fail. 2021 Dec 18;:

Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.

Ferreira JP, Rossignol P, Bakris G, Mehta C, White WB, Zannad F

Am J Nephrol. 2021 Dec 6;:1-8

Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.

Butler J, Anker SD, Siddiqi TJ, Coats AJS, Dorigotti F, Filippatos G, Friede T, Göhring UM, Kosiborod MN, Lund LH, Metra M, Quinn CM, Piña IL, Pinto FJ, Rossignol P, Szecsödy P, der Meer PV, Weir M, Pitt B

Eur J Heart Fail. 2021 Nov 20;:

Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort.

Chouihed T, Bassand A, Duarte K, Jaeger D, Roth Y, Giacomin G, Delaruelle A, Duchanois C, Bannay A, Kobayashi M, Rossignol P, Girerd N

Intern Emerg Med. 2021 Nov 17;:

Digital health and artificial intelligence in kidney research: a report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting.

Yi TW, Laing C, Kretzler M, Nkulikiyinka R, Legrand M, Jardine M, Rossignol P, Smyth B

Nephrol Dial Transplant. 2021 Nov 13;:

Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics.

Barrera-Chimal J, Kolkhof P, Lima-Posada I, Joachim A, Rossignol P, Jaisser F

Expert Opin Investig Drugs. 2021 Nov 11;:

Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT.

Ferreira JP, Rossignol P, Claggett BL, Solomon SD, Pitt B, Pfeffer M, Zannad F

Clin Res Cardiol. 2021 Nov 10;:

No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial.

Ferreira JP, Girerd N, Rocca HB, Pellicori P, Cleland JG, Rossignol P, Zannad F

Arch Cardiovasc Dis. 2021 Nov 9;:

Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort.

Xhaard C, Rouget R, Vodovar N, Le Floch E, Dandine-Roulland C, Wagner S, Bacq-Daian D, Thuillier Q, Boivin JM, Branlant C, Deleuze JF, Behm-Ansmant I, Zannad F, Rossignol P, Girerd N

ESC Heart Fail. 2021 Nov 3;:

Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort.

Xhaard C, Dandine-Roulland C, Villemereuil P, Floch EL, Bacq-Daian D, Machu JL, Ferreira JP, Deleuze JF, Zannad F, Rossignol P, Girerd N

Eur J Prev Cardiol. 2021 Oct 13;28(12):1334-1341

A Step Forward Toward a New Treatment Paradigm in the Cardiorenal Continuum.

Rossignol P

JACC Heart Fail. 2021 Sep 29;:

Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort.

Monzo L, Ferreira JP, Lamiral Z, Bozec E, Boivin JM, Huttin O, Lopez-Sublet M, Girerd N, Zannad F, Rossignol P

Clin Cardiol. 2021 Sep 15;:

Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial.

Ferreira JP, Rossignol P, Bakris G, Mehta C, White WB, Zannad F

Cardiovasc Diabetol. 2021 Sep 14;20(1):187

Haemodynamic parameters associated with renal function prior to and following heart transplantation.

Baudry G, Sebbag L, Bourdin J, Hugon-Vallet E, Jobbe Duval A, Mewton N, Pozzi M, Rossignol P, Girerd N

ESC Heart Fail. 2021 Sep 14;:

Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy.

Evangelidis N, Sautenet B, Madero M, Tong A, Ashuntantang G, Sanabria LC, de Boer IH, Fung S, Gallego D, Levey AS, Levin A, Lorca E, Okpechi IG, Rossignol P, Sola L, Usherwood T, Wheeler DC, Cho Y, Howell M, Guha C, Scholes-Robertson N, Widders K, Gonzalez AM, Teixeira-Pinto A, Viecelli AK, Bernier-Jean A, Anumudu S, Dunn L, Wilkie M, Craig JC,

Trials. 2021 Sep 9;22(1):612

Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals.

Kobayashi M, Huttin O, Magnusson M, Ferreira JP, Bozec E, Huby AC, Preud'homme G, Duarte K, Lamiral Z, Dalleau K, Bresso E, Smaïl-Tabbone M, Devignes MD, Nilsson PM, Leosdottir M, Boivin JM, Zannad F, Rossignol P, Girerd N,

JACC Cardiovasc Imaging. 2021 Sep 8;:

Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation.

Noirclerc N, Huttin O, de Chillou C, Selton-Suty C, Fillipetti L, Sellal JM, Bozec E, Donal E, Lamiral Z, Kobayashi M, Ferreira JP, Rossignol P, Girerd N

J Clin Med. 2021 Aug 30;10(17):

A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk.

Zoccali C, Torino C, Mallamaci F, Sarafidis P, Papagianni A, Ekart R, Hojs R, Klinger M, Letachowicz K, Fliser D, Seiler-Mußler S, Lizzi F, Wiecek A, Miskiewicz A, Siamopoulos K, Balafa O, Slotki I, Shavit L, Stavroulopoulos A, Covic A, Siriopol D, Massy ZA, Seidowsky A, Battaglia Y, Martinez-Castelao A, Polo-Torcal C, Coudert-Krier MJ, Rossignol P, Fiaccadori E, Regolisti G, Hannedouche T, Bachelet T, Jager KJ, Dekker FW, Tripepi R, Tripepi G, Gargani L, Sicari R, Picano E, London GM

Kidney Int. 2021 Aug 18;:

Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.

Verdonschot JAJ, Ferreira JP, Pellicori P, Brunner-La Rocca HP, Clark AL, Cosmi F, Cuthbert J, Girerd N, Mariottoni B, Petutschnigg J, Rossignol P, Cleland JGF, Zannad F, Heymans SRB,

Cardiovasc Diabetol. 2021 Aug 9;20(1):163

Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD Trial.

Brandt-Jacobsen NH, Lav Madsen P, Johansen ML, Rasmussen JJ, Forman JL, Holm MR, Rye Jørgensen N, Faber J, Rossignol P, Schou M, Kistorp C

JACC Heart Fail. 2021 Aug;9(8):550-558

Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.

Rossignol P, Pitt B

J Am Coll Cardiol. 2021 Jul 27;78(4):344-347

Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.

Valdivielso JM, Balafa O, Ekart R, Ferro CJ, Mallamaci F, Mark PB, Rossignol P, Sarafidis P, Del Vecchio L, Ortiz A

Drugs. 2021 Jul 27;:

The "Peptide for Life" Initiative: A Call for Action to Provide Equal Access for the Use of Natriuretic Peptides in the Diagnosis of Acute Heart Failure across Europe.

Bayes-Genis A, Januzzi JL, Richards AM, Arfsten H, de Boer RA, Emdin M, González A, Jaarsma T, Jhund PS, Mueller C, Núñez J, Rossignol P, Milinkovic I, Rosano GM, Coats A, Seferovic P

Eur J Heart Fail. 2021 Jul 7;:

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial.

Ferreira JP, Ferrao D, Rossignol P, Zannad F, Sharma A, Vasques-Novoa F, Leite-Moreira A

BMJ Open Diabetes Res Care. 2021 Jul;9(1):

Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.

Salib M, Girerd S, Girerd N, März W, Scharnagl H, Massy ZA, Leroy C, Duarte K, Holdaas H, Jardine AG, Schmieder RE, Fellström B, López-Andrés N, Rossignol P, Zannad F

Clin Res Cardiol. 2021 Jun 25;:

Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER).

Agarwal R, Rossignol P, Mayo M, Conrad A, Arthur S, Williams B, White W

Clin J Am Soc Nephrol. 2021 Jun 23;:

Identification of sex-specific biomarkers predicting new-onset heart failure.

Raafs A, Verdonschot J, Ferreira JP, Wang P, Collier T, Henkens M, Björkman J, Boccanelli A, Clark AL, Delles C, Diez J, González A, Girerd N, Jukema JW, Pinet F, Rossignol P, Thum T, Vodovar N, de Boer RA, van Empel V, Staessen JA, Hazebroek M, Cleland J, Zannad F, Heymans S

ESC Heart Fail. 2021 Jun 22;:

Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein.

Jover E, Matilla L, Garaikoetxea M, Fernández-Celis A, Muntendam P, Jaisser F, Rossignol P, López-Andrés N

Biomedicines. 2021 Jun 3;9(6):

Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial.

Ferreira JP, Lamiral Z, McMurray JJV, Swedberg K, van Veldhuisen DJ, Vincent J, Rossignol P, Pocock SJ, Pitt B, Zannad F

Circ Heart Fail. 2021 Jun;14(6):e008075

Dosing of losartan in men vs. women with HFrEF: the HEAAL trial.

Ferreira JP, Konstam MA, McMurray JJV, Butler J, Girerd N, Rossignol P, Sharma A, Voors AA, Lam CSP, Packer M, Zannad F

Eur J Heart Fail. 2021 May 29;:

Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension.

Halimi JM, Ortiz A, Sarafidis PA, Mallamaci F, Wuerzner G, Pisano A, London G, Persu A, Rossignol P, Sautenet B, Ferro C, Boletis J, Kanaan N, Vogt L, Bolignano D, Burnier M, Zoccali C

J Hypertens. 2021 May 28;:

Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program.

Rossignol P, David L, Chan C, Conrad A, Weir MR

Drugs Real World Outcomes. 2021 May 20;:

[Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study].

Rossignol P,

Nephrol Ther. 2021 May 11;:

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure.

Kobayashi M, Voors AA, Ouwerkerk W, Duarte K, Girerd N, Rossignol P, Metra M, Lang CC, Ng LL, Filippatos G, Dickstein K, van Veldhuisen DJ, Zannad F, Ferreira JP

Clin Cardiol. 2021 May 7;:

Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.

Coiro S, Girerd N, McMurray JJV, Pitt B, Swedberg K, van Veldhuisen DJ, Lamiral Z, Rossignol P, Zannad F

Clin Res Cardiol. 2021 May 6;:

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.

Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, Mark PB, Persu A, Rossignol P, Ruilope LM, Schmieder RE, Valdivielso JM, Del Vecchio L, Zoccali C, Mallamaci F, Sarafidis P,

Nephrol Dial Transplant. 2021 May 4;:

Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial.

Martens P, Ferreira JP, Vincent J, Abreu P, Busselen M, Mullens W, Tang WWH, Böhm M, Pitt B, Zannad F, Rossignol P

Clin Res Cardiol. 2021 Apr 23;:

Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.

Ishida JH, Chauhan C, Gillespie B, Gruchalla K, McCullough PA, Quella S, Romero A, Rossignol P, Wheeler DC, Malley MA, West M, Herzog CA

Clin J Am Soc Nephrol. 2021 Apr 23;:

Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review.

Gault N, Esposito-Farese M, Revest M, Inamo J, Cabie A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, de Montmollin E, Oziol E, Etienne M, Laouenan C, Rossignol P, Costagliola D, Vidal-Petiot E,

Fundam Clin Pharmacol. 2021 Apr 20;:

Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trial.

Ferreira JP, Gregson J, Böhm M, Rossignol P, Zannad F, Pocock SJ

Clin Cardiol. 2021 Apr 6;:

Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.

Ferreira JP, Collier T, Clark AL, Mamas MA, Rocca HB, Heymans S, González A, Ahmed FZ, Petutschnigg J, Mujaj B, Cuthbert J, Rouet P, Pellicori P, Mariottoni B, Cosmi F, Edelmann F, Thijs L, Staessen JA, Hazebroek M, Verdonschot J, Rossignol P, Girerd N, Cleland JG, Zannad F

Eur Heart J Cardiovasc Pharmacother. 2021 Apr 2;:

Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage.

Pisano A, Mallamaci F, D'Arrigo G, Bolignano D, Wuerzner G, Ortiz A, Burnier M, Kanaan N, Sarafidis P, Persu A, Ferro CJ, Loutradis C, Boletis IN, London G, Halimi JM, Sautenet B, Rossignol P, Vogt L, Zoccali C

Nephrol Dial Transplant. 2021 Mar 25;:

Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial.

Agarwal R, Rossignol P, Budden J, Mayo MR, Arthur S, Williams B, White WB

Kidney360. 2021 Mar 25;2(3):425-434

The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure.

Pandhi P, Streng KW, Anker SD, Cleland JG, Damman K, Dickstein K, Pellicori P, Lang CC, Ng L, Samani NJ, Zannad F, Metra M, Rossignol P, Filippatos G, van Veldhuisen DJ, Voors AA, Ter Maaten JM

J Cachexia Sarcopenia Muscle. 2021 Mar 20;:

Mineralocorticoid Receptor Antagonists and SGLT2 Inhibitor Therapy: The Best of Both Worlds in HFrEF.

Zannad F, Rossignol P

JACC Heart Fail. 2021 Mar 5;:

Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.

Stienen S, Ferreira JP, Bär C, Thum T, Barros A, Pitt B, Girerd N, Rossignol P, Zannad F

Int J Cardiol. 2021 Mar 4;:

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score.

Huttin O, Fraser AG, Lund LH, Donal E, Linde C, Kobayashi M, Erdei T, Machu JL, Duarte K, Rossignol P, Paulus W, Zannad F, Girerd N,

ESC Heart Fail. 2021 Mar 3;:

Should renin angiotensin aldosterone system inhibition enablement be a therapeutic target in CKD patients?

Rossignol P, Agarwal R

Nephrol Dial Transplant. 2021 Mar 2;:

Head-to-head comparison of clustering methods for heterogeneous data: a simulation-driven benchmark.

Preud'homme G, Duarte K, Dalleau K, Lacomblez C, Bresso E, Smaïl-Tabbone M, Couceiro M, Devignes MD, Kobayashi M, Huttin O, Ferreira JP, Zannad F, Rossignol P, Girerd N

Sci Rep. 2021 Feb 18;11(1):4202

Circulating multimarker approach to identify patients with preclinical left ventricular remodelling and/or diastolic dysfunction.

Huttin O, Kobayashi M, Ferreira JP, Coiro S, Bozec E, Selton-Suty C, Filipetti L, Lamiral Z, Rossignol P, Zannad F, Girerd N

ESC Heart Fail. 2021 Feb 12;:

Impact of anti-hypertensive therapy in the sexual health of men and women: an analysis from the SPRINT trial.

Ferreira JP, Böhm M, Rossignol P, Zannad F

Am J Hypertens. 2021 Feb 11;:

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models.

Bonnard B, Martínez-Martínez E, Fernández-Celis A, Pieronne-Deperrois M, Do QT, Ramos I, Rossignol P, Zannad F, Mulder P, Ouvrard-Pascaud A, López-Andrés N, Jaisser F

Sci Rep. 2021 Jan 28;11(1):2591

Impact of Geographic Region on the COMMANDER-HF Trial.

Ferreira JP, Cleland JGF, Lam CSP, van Veldhuisen D, Byra WM, La Police DA, Anker SD, Mehra MR, Leroy C, Eschwege V, Toussaint-Hacquard M, Rossignol P, Greenberg B, Zannad F

JACC Heart Fail. 2021 Jan 28;:

Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF.

Ferreira JP, Verdonschot J, Wang P, Pizard A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F, Cuthbert J, Díez J, Edelmann F, Girerd N, González A, Grojean S, Hazebroek M, Khan J, Latini R, Mamas MA, Mariottoni B, Mujaj B, Pellicori P, Petutschnigg J, Pieske B, Rossignol P, Rouet P, Staessen JA, Cleland JGF, Heymans S, Zannad F,

JACC Heart Fail. 2021 Jan 28;:

Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance.

Girerd N, Aubry M, Lantelme P, Huttin O, Rossignol P

Int Heart J. 2021 Jan 16;:

Sarcopenia in patients after an episode of acute decompensated heart failure: An underdiagnosed problem with serious impact.

Eschalier R, Massoullié G, Boirie Y, Blanquet M, Mulliez A, Tartière PL, Anker S, D'Agrosa Boiteux MC, Richard R, Jean F, Combaret N, Souteyrand G, Riocreux C, Pereira B, Motreff P, Stolt P, Rossignol P, Clerfond G

Clin Nutr. 2021 Jan 9;:

Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials.

Patel RB, Ter Maaten JM, Ferreira JP, Mc Causland FR, Shah SJ, Rossignol P, Solomon SD, Vaduganathan M, Packer M, Thompson A, Stockbridge N, Zannad F

Circulation. 2021 Jan 7;:

Estimated plasma volume status in heart failure: clinical implications and future directions.

Kobayashi M, Girerd N, Duarte K, Chouihed T, Chikamori T, Pitt B, Zannad F, Rossignol P

Clin Res Cardiol. 2021 Jan 6;:

A Combination of Chest Radiography and Estimated Plasma Volume May Predict In-Hospital Mortality in Acute Heart Failure.

Kobayashi M, Douair A, Coiro S, Giacomin G, Bassand A, Jaeger D, Duarte K, Huttin O, Zannad F, Rossignol P, Chouihed T, Girerd N

Front Cardiovasc Med. 2021 ;8:752915

Arterial and Cardiac Remodeling Associated With Extra Weight Gain in an Isolated Abdominal Obesity Cohort.

Mandry D, Girerd N, Lamiral Z, Huttin O, Filippetti L, Micard E, Ncho Mottoh MB, Böhme P, Chemla D, Zannad F, Rossignol P, Marie PY

Front Cardiovasc Med. 2021 ;8:771022

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis.

Kobayashi M, Ferreira MB, Costa RQ, Fonseca T, Oliveira JC, Marinho A, Carvalho HC, Girerd N, Rossignol P, Zannad F, Rodrigues P, Ferreira JP

Front Cardiovasc Med. 2021 ;8:754784

Quality of Beverage Intake and Cardiometabolic and Kidney Outcomes: Insights From the STANISLAS Cohort.

Wagner S, Merkling T, Girerd N, Bozec E, Van den Berghe L, Hoge A, Guillaume M, Kanbay M, Cakir-Kiefer C, Thornton SN, Boivin JM, Mercklé L, Laville M, Rossignol P, Nazare JA

Front Nutr. 2021 ;8:738803

Relationship Between Left Ventricular Ejection Fraction Variation and Systemic Vascular Resistance: A Prospective Cardiovascular Magnetic Resonance Study.

Mandry D, Girerd N, Lamiral Z, Huttin O, Filippetti L, Micard E, Beaumont M, Ncho Mottoh MB, Pace N, Zannad F, Rossignol P, Marie PY

Front Cardiovasc Med. 2021 ;8:803567

Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis.

Ng JK, Smyth B, Marshall MR, Kang A, Pinter J, Bassi A, Krishnasamy R, Rossignol P, Rocco MV, Li Z, Jha V, Hawley CM, Kerr PG, DI Tanna GL, Woodward M, Jardine AM

Nephrol Dial Transplant. 2020 Dec 26;:

The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.

Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, Petutschnigg J, Ahmed FZ, Cosmi F, Brunner La Rocca HP, Mamas MA, Clark AL, Edelmann F, Pieske B, Khan J, McDonald K, Rouet P, Staessen JA, Mujaj B, González A, Diez J, Hazebroek M, Heymans S, Latini R, Grojean S, Pizard A, Girerd N, Rossignol P, Collier TJ, Zannad F

Eur Heart J. 2020 Nov 20;:

Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study.

Ferreira MB, Fonseca T, Costa R, Marinhoc A, Carvalho HC, Oliveira JC, Zannad F, Rossignol P, Gottenberg JE, Saraiva FA, Rodrigues P, Barros AS, Ferreira JP

Eur J Intern Med. 2020 Nov 6;:

Diagnostic performance of congestion score index evaluated from chest radiography for acute heart failure in the emergency department: A retrospective analysis from the PARADISE cohort.

Kobayashi M, Douair A, Duarte K, Jaeger D, Giacomin G, Bassand A, Jeangeorges V, Vuillaume LA, Preud'homme G, Huttin O, Zannad F, Rossignol P, Chouihed T, Girerd N

PLoS Med. 2020 Nov;17(11):e1003419

Dyskalemia: a management problem for students.

Senninger L, Abensur Vuillaume L, Frimat L, Girerd N, Lamiral Z, Rossignol P, Boivin JM

Fundam Clin Pharmacol. 2020 Oct 24;:

The Mineralocorticoid Receptor Antagonist Eplerenone Suppress Interstitial Fibrosis in Subcutaneous Adipose Tissue in Type 2 Diabetes Patients.

Johansen ML, Ibarrola J, Fernández-Celis A, Schou M, Sonne MP, Holm MR, Rasmussen J, Dela F, Jaisser F, Faber J, Rossignol P, Lopez-Andres N, Kistorp C

Diabetes. 2020 Oct 14;:

Plasma Volume Status and its Association with In-Hospital and Post-Discharge Outcomes in Decompensated Heart Failure.

Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM, Mentz RJ

J Card Fail. 2020 Oct 7;:

Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Lindner G, Burdmann EA, Clase CM, Hemmelgarn BR, Herzog CA, Małyszko J, Nagahama M, Pecoits-Filho R, Rafique Z, Rossignol P, Singer AJ

Eur J Emerg Med. 2020 Oct;27(5):329-337

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.

Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen J, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, ,,,,,,,,,,Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL

Science. 2020 Sep 24;:

Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies.

Kanbay M, Siriopol D, Copur S, Tapoi L, Benchea L, Kuwabara M, Rossignol P, Ortiz A, Covic A, Afsar B

J Ren Nutr. 2020 Sep 18;:

Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial.

Brandt-Jacobsen NH, Johansen ML, Rasmussen J, Forman JL, Holm MR, Faber J, Rossignol P, Schou M, Kistorp C

Diabetes Metab.. 2020 Sep 9;:

Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.

Hui SK, Sharma A, Docherty K, McMurray JJV, Pitt B, Dickstein K, Pfeffer MA, Girerd N, Rossignol P, Ferreira JP, Zannad F

Eur Heart J Acute Cardiovasc Care. 2020 Aug 28;:

Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA).

Montassier E, Lemoine L, Hardouin JB, Rossignol P, Legrand M

BMJ Open. 2020 Aug 26;10(8):e039277

Sex differences in circulating proteins in heart failure with preserved ejection fraction.

Stienen S, Ferreira JP, Kobayashi M, Preud'homme G, Dobre D, Machu JL, Duarte K, Bresso E, Devignes MD, Andrés NL, Girerd N, Aakhus S, Ambrosio G, Rocca HB, Fontes-Carvalho R, Fraser AG, van Heerebeek L, de Keulenaer G, Marino P, McDonald K, Mebazaa A, Papp Z, Raddino R, Tschöpe C, Paulus WJ, Zannad F, Rossignol P

Biol Sex Differ. 2020 Aug 24;11(1):47

Serum Potassium in the PARADIGM-HF trial.

Ferreira JP, Mogensen UM, Jhund PS, Desai AS, Rouleau JL, Zile MR, Rossignol P, Zannad F, Packer M, Solomon SD, McMurray JJV

Eur. J. Heart Fail.. 2020 Aug 18;:

Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.

Ferreira JP, Sharma A, Mehta C, Bakris G, Rossignol P, White WB, Zannad F

Clin Res Cardiol. 2020 Aug 13;:

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches.

Stienen S, Bhatt A, Ferreira JP, Vaduganathan M, Januzzi J, Adams K, Tardif JC, Rossignol P, Zannad F

Heart Fail Rev. 2020 Aug 12;:

Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies.

Kobayashi M, Gargani L, Palazzuoli A, Ambrosio G, Bayés-Genis A, Lupon J, Pellicori P, Pugliese NR, Reddy YNV, Ruocco G, Duarte K, Huttin O, Rossignol P, Coiro S, Girerd N

Clin Res Cardiol. 2020 Aug 8;:

Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.

Elharram M, Sharma A, White W, Bakris G, Rossignol P, Mehta C, Ferreira JP, Zannad F

Am. Heart J.. 2020 Aug 6;229:40-51

Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: a European multi-national targeted chart review.

Rossignol P, Ruilope LM, Cupisti A, Ketteler M, Wheeler DC, Pignot M, Cornea G, Schulmann T, Lund LH

Clin Kidney J. 2020 Aug;13(4):714-719

Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer.

Copur S, Sag AA, Afsar B, Rossignol P, Covic A, Kanbay M

Int Urol Nephrol. 2020 Jul 13;:

Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.

Mewton N, Girerd N, Boffa JJ, Courivaud C, Isnard R, Juillard L, Lamblin N, Legrand M, Logeart D, Mariat C, Meune E, Sabouret P, Sebbag L, Rossignol P

Arch Cardiovasc Dis. 2020 Jul 10;:

Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1.

Matilla L, Arrieta V, Jover E, Garcia-Peña A, Martinez-Martinez E, Sadaba R, Alvarez V, Navarro A, Fernandez-Celis A, Gainza A, Santamaria E, Fernandez-Irigoyen J, Rossignol P, Zannad F, Lopez-Andres N

Cells. 2020 Jul 10;9(7):

The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.

Legrand M, Oufella HA, De Backer D, Duranteau J, Leone M, Levy B, Rossignol P, Vicaut E, Dépret F,

Trials. 2020 Jul 1;21(1):601

Hyperkalaemia and hypokalaemia outpatient management: a survey of 500 French general practitioners.

Abensur Vuillaume L, Rossignol P, Lamiral Z, Girerd N, Boivin JM

ESC Heart Fail. 2020 Jun 29;:

Left ventricular myocardial deformation pattern, mechanical dispersion, and their relation with electrocardiogram markers in the large population-based STANISLAS cohort: insights into electromechanical coupling.

Verdugo-Marchese M, Coiro S, Selton-Suty C, Kobayashi M, Bozec E, Lamiral Z, Venner C, Zannad F, Rossignol P, Girerd N, Huttin O

Eur Heart J Cardiovasc Imaging. 2020 Jun 24;:

Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.

Ferreira JP, Butler J, Rossignol P, Pitt B, Anker SD, Kosiborod M, Lund LH, Bakris GL, Weir MR, Zannad F

J. Am. Coll. Cardiol.. 2020 Jun 9;75(22):2836-2850

Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial.

Ferreira JP, Mehta C, Sharma A, Nissen SE, Rossignol P, Zannad F

BMC Med. 2020 Jun 4;18(1):165

Cardiovascular Consequences of Acute Kidney Injury.

Legrand M, Rossignol P

N. Engl. J. Med.. 2020 06 4;382(23):2238-2247

Circulating plasma proteins and new-onset diabetes in a population-based study: proteomic and genomic insights from the STANISLAS cohort.

Ferreira JP, Lamiral Z, Xhaard C, Duarte K, Bresso E, Devignes MD, Lefloch E, Roulland CD, Deleuze JF, Wagner S, Guerci B, Girerd N, Zannad F, Boivin JM, Rossignol P

Eur. J. Endocrinol.. 2020 Jun 1;:

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure.

Rossignol P, Williams B, Mayo MR, Warren S, Arthur S, Ackourey G, White WB, Agarwal R

Eur. J. Heart Fail.. 2020 May 25;:

Spironolactone dose in Heart Failure with Preserved Ejection Fraction: findings from TOPCAT.

Ferreira JP, Rossello X, Pocock SJ, Rossignol P, Claggett BL, Rouleau JL, Solomon SD, Pitt B, Pfeffer MA, Zannad F

Eur. J. Heart Fail.. 2020 May 25;:

Empagliflozin for Patients with Presumed Resistant Hypertension: a Post Hoc Analysis of the EMPA-REG OUTCOME Trial.

Ferreira JP, Fitchett D, Ofstad AP, Kraus BJ, Wanner C, Zwiener I, Zinman B, Lauer S, George JT, Rossignol P, Zannad F

Am. J. Hypertens.. 2020 May 5;:

Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial.

Ferreira JP, Eschalier R, Duarte K, Damman K, Gustafsson F, Schou M, Girerd N, Fay R, Tala S, Pitt B, Zannad F, Rossignol P

Circ Heart Fail. 2020 May;13(5):e006597

Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients.

Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F

Eur. J. Heart Fail.. 2020 Apr 30;:

A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse.

Ibarrola J, Garcia-Peña A, Matilla L, Bonnard B, Sádaba R, Arrieta V, Alvarez V, Fernández-Celis A, Gainza A, Navarro A, Alvarez de la Rosa D, Rossignol P, Jaisser F, López-Andrés N

Circ. Res.. 2020 Apr 24;:

Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach.

Bayes-Genis A, Bisbal F, Núñez J, Santas E, Lupón J, Rossignol P, Paulus W

J Clin Med. 2020 Apr 13;9(4):

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study.

Akiyama E, Cinotti R, Čerlinskaitė K, Van Aelst LNL, Arrigo M, Placido R, Chouihed T, Girerd N, Zannad F, Rossignol P, Badoz M, Launay JM, Gayat E, Cohen-Solal A, Lam CSP, Testani J, Mullens W, Cotter G, Seronde MF, Mebazaa A

ESC Heart Fail. 2020 Apr 11;:

Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge.

Rossignol P, Fay R, Girerd N, Zannad F

ESC Heart Fail. 2020 Apr 10;:

Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.

Kanbay M, Girerd N, Machu JL, Bozec E, Duarte K, Boivin JM, Wagner S, Ferreira JP, Zannad F, Rossignol P

Am. J. Hypertens.. 2020 Apr 8;:

Association of Dietary Patterns Derived Using Reduced-Rank Regression With Subclinical Cardiovascular Damage According to Generation and Sex in the STANISLAS Cohort.

Wagner S, Lioret S, Girerd N, Duarte K, Lamiral Z, Bozec E, Van den Berghe L, Hoge A, Donneau AF, Boivin JM, Mercklé L, Zannad F, Laville M, Rossignol P, Nazare JA

J Am Heart Assoc. 2020 Apr 7;9(7):e013836

PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort.

Ferreira JP, Xhaard C, Lamiral Z, Borges-Canha M, Neves JS, Dandine-Roulland C, LeFloch E, Deleuze JF, Bacq-Daian D, Bozec E, Girerd N, Boivin JM, Zannad F, Rossignol P

J Am Heart Assoc. 2020 Apr 7;9(7):e014758

Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction.

Kobayashi M, Girerd N, Duarte K, Preud'homme G, Pitt B, Rossignol P

Clin Res Cardiol. 2020 Apr 6;:

Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure.

Stienen S, Ferreira JP, Pitt B, Cleland JG, Pellicori P, Girerd N, Rossignol P, Zannad F

Eur. J. Heart Fail.. 2020 Apr 3;:

Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.

Rossignol P, Lainscak M, Crespo-Leiro MG, Laroche C, Piepoli MF, Filippatos G, Rosano GMC, Savarese G, Anker SD, Seferovic PM, Ruschitzka F, Coats AJS, Mebazaa A, McDonagh T, Sahuquillo A, Penco M, Maggioni AP, Lund LH,

Eur. J. Heart Fail.. 2020 Apr 3;:

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.

Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Lüscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP, Sievert H, Volpe M, Weber MA, Schmieder RE, Tsioufis C, Wijns W

Eur. Heart J.. 2020 Mar 25;:

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure.

Kobayashi M, Stienen S, Ter Maaten JM, Dickstein K, Samani NJ, Lang CC, Ng LL, Anker SD, Metra M, Preud'homme G, Duarte K, Lamiral Z, Girerd N, Rossignol P, van Veldhuisen DJ, Voors AA, Zannad F, Ferreira JP

ESC Heart Fail. 2020 Mar 13;:

Hypo- and hyperkalaemia in heart failure. Navigating between Scylla and Charybdis.

Rossignol P, Zannad F

Eur. J. Heart Fail.. 2020 Mar 13;:

Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.

Böhm M, Ferreira JP, Mahfoud F, Duarte K, Pitt B, Zannad F, Rossignol P

Eur. Heart J.. 2020 Mar 2;:

Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials.

Rossello X, Ferreira JP, Pocock SJ, McMurray JJV, Solomon SD, Lam CSP, Girerd N, Pitt B, Rossignol P, Zannad F

Eur. J. Heart Fail.. 2020 Feb 19;:

Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).

Stienen S, Ferreira JP, Kobayashi M, Preud'homme G, Dobre D, Machu JL, Duarte K, Bresso E, Devignes MD, López N, Girerd N, Aakhus S, Ambrosio G, Brunner-La Rocca HP, Fontes-Carvalho R, Fraser AG, van Heerebeek L, Heymans S, de Keulenaer G, Marino P, McDonald K, Mebazaa A, Papp Z, Raddino R, Tschöpe C, Paulus WJ, Zannad F, Rossignol P

Biomarkers. 2020 Feb 16;:1-11

Spironolactone for resistant hypertension in advanced chronic kidney disease-red, amber or green?

Agarwal R, Rossignol P, Williams B, White WB

Nephrol. Dial. Transplant.. 2020 Feb 11;:

Longer Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension.

Triantafyllou A, Ferreira JP, Kobayashi M, Micard E, Xie Y, Kearney-Schwartz A, Hossu G, Rossignol P, Bracard S, Benetos A

J. Alzheimers Dis.. 2020 Feb 6;:

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial.

Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, Fellström B, Settembre N, Malikov S, Rossignol P, Zannad F

Clin Kidney J. 2020 Feb;13(1):116-122

Association of estimated plasma volume status with hemodynamic and echocardiographic parameters.

Kobayashi M, Huttin O, Donal E, Duarte K, Hubert A, Le Breton H, Galli E, Fournet M, Mabo P, Schnell F, Leclercq C, Rossignol P, Girerd N

Clin Res Cardiol. 2020 Jan 31;:

Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.

Kanbay M, Afsar B, Siriopol D, Dincer N, Erden N, Yilmaz O, Sag AA, Kuwabara M, Cherney D, Rossignol P, Ortiz A, Covic A

Angiology. 2020 Jan 31;:3319719897509

Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE-HF trial.

Ferreira JP, Duarte K, Woehrle H, Cowie MR, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, Levy P, Simonds AK, Somers VK, Teschler H, Rossignol P, Koenig W, Zannad F

ESC Heart Fail. 2020 Jan 17;:

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HO

Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, Ahmed FZ, Verdonschot J, Collier T, Cuthbert JJ, Petutschnigg J, Mujaj B, Girerd N, González A, Clark AL, Cosmi F, Staessen JA, Heymans S, Latini R, Rossignol P, Zannad F, Cleland JGF

Eur. J. Heart Fail.. 2020 Jan 16;:

Predictors of sudden cardiac death in high-risk patients following a myocardial infarction.

Docherty KF, Ferreira JP, Sharma A, Girerd N, Gregson J, Duarte K, Petrie MC, Jhund PS, Dickstein K, Pfeffer MA, Pitt B, Rossignol P, Zannad F, McMurray JJV

Eur. J. Heart Fail.. 2020 Jan 16;:

Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction.

Rossignol P, Duarte K, Girerd N, Karoui M, McMurray JJV, Swedberg K, van Veldhuisen DJ, Pocock S, Dickstein K, Zannad F, Pitt B

Eur. J. Heart Fail.. 2020 Jan 9;:

Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.

Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Regolisti G, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Hannedouche T, Wiecek A, Sarafidis P, Battaglia Y, Prohić N, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Loutradis C, Seidowsky A, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C

J. Nephrol.. 2020 Jan 8;:

Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology.

Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, Tang WHW, Skouri H, Verbrugge FH, Orso F, Hill L, Dilek U, Lainscak M, Rossignol P, Metra M, Mebazaa A, Seferovic P, Ruschitzka F, Coats A

Eur. J. Heart Fail.. 2020 Jan 7;:

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.

Serenelli M, Jackson A, Dewan P, Jhund PS, Petrie MC, Rossignol P, Campo G, Pitt B, Zannad F, Ferreira JP, McMurray JJV

JACC Heart Fail. 2020 Jan 6;:

Hypokalemia is frequent and has prognostic implications in stable patients attending the emergency department.

Abensur Vuillaume L, Ferreira JP, Asseray N, Trombert-Paviot B, Montassier E, Legrand M, Girerd N, Boivin JM, Chouihed T, Rossignol P

PLoS ONE. 2020 ;15(8):e0236934

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids.

de Gonzalo-Calvo D, Martínez-Camblor P, Bär C, Duarte K, Girerd N, Fellström B, Schmieder RE, Jardine AG, Massy ZA, Holdaas H, Rossignol P, Zannad F, Thum T

Theranostics. 2020 ;10(19):8665-8676

Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study.

Huttin O, Mandry D, Popovic B, Rossignol P, Odille F, Micard E, Lamiral Z, Zannad F, Girerd N, Marie PY

PLoS ONE. 2020 ;15(5):e0232572

Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort.

Xhaard C, Dandine-Roulland C, Villemereuil P, Floch EL, Bacq-Daian D, Machu JL, Ferreira JP, Deleuze JF, Zannad F, Rossignol P, Girerd N

Eur J Prev Cardiol. 2019 Dec 2;:2047487319890763

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT.

Ferreira JP, Rossello X, Eschalier R, McMurray JJV, Pocock S, Girerd N, Rossignol P, Pitt B, Zannad F

JACC Heart Fail. 2019 Dec;7(12):1012-1021

Renal function, electrolytes, and congestion monitoring in heart failure.

Rossignol P, Coats AJ, Chioncel O, Spoletini I, Rosano G

Eur Heart J Suppl. 2019 Dec;21(Suppl M):M25-M31

Insulin-like growth factor binding protein 2: A prognostic biomarker for heart failure hardly redundant with natriuretic peptides.

Girerd N, Bresso E, Devignes MD, Rossignol P

Int. J. Cardiol.. 2019 Nov 13;:

Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF.

Kobayashi M, Voors AA, Girerd N, Billotte M, Anker SD, Cleland JG, Lang CC, Ng LL, van Veldhuisen DJ, Dickstein K, Metra M, Duarte K, Rossignol P, Zannad F, Ferreira JP

Eur. J. Intern. Med.. 2019 Nov 7;:

Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study.

Hamdidouche I, Gosse P, Cremer A, Lorthioir A, Delsart P, Courand PY, Denolle T, Halimi JM, Girerd X, Ormezzano O, Rossignol P, Pereira H, Azizi M,

Hypertension. 2019 Nov;74(5):1096-1103

Telomere length tracking in children and their parents: implications for adult onset diseases.

Benetos A, Verhulst S, Labat C, Lai TP, Girerd N, Toupance S, Zannad F, Rossignol P, Aviv A

FASEB J.. 2019 Oct 25;:fj201901275R

Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial?

Agarwal R, Rossignol P

Nephrol. Dial. Transplant.. 2019 Oct 3;:

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial.

Monzo L, Ferreira JP, Abreu P, Szumski A, Böhm M, McMurray JJV, Pitt B, Swedberg K, van Veldhuisen DJ, Girerd N, Vincent J, Zannad F, Rossignol P

J. Hypertens.. 2019 Oct 3;:

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.

Agarwal R, Rossignol P, Romero A, Garza D, Mayo MR, Warren S, Ma J, White WB, Williams B

Lancet. 2019 Sep 13;:

Emerging Drug Classes and Their Potential Use in Hypertension.

Azizi M, Rossignol P, Hulot JS

Hypertension. 2019 Sep 9;:HYPERTENSIONAHA11912676

Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial.

Ferreira JP, Rossello X, Pitt B, Rossignol P, Zannad F

Clin Cardiol. 2019 Sep 3;:

Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure.

Coiro S, Girerd N, Sharma A, Rossignol P, Tritto I, Pitt B, Pfeffer MA, McMurray JJV, Ambrosio G, Dickstein K, Moss A, Zannad F

Eur. J. Heart Fail.. 2019 Sep 2;:

Income level and inequality as complement to geographical differences in cardiovascular trials.

Ferreira JP, Rossignol P, Dewan P, Lamiral Z, White WB, Pitt B, McMurray JJV, Zannad F

Am. Heart J.. 2019 Sep 1;218:66-74

Correlation of Quantitated Intravascular Volume with Blood Pressure in Patients with Systemic Hypertension.

Fudim M, Blumer VL, Lopes RD, Rossignol P, Feldschuh M, Miller WL, Sobotka PA

J Cardiovasc Transl Res. 2019 Aug 28;:

Accuracy of several lung ultrasound methods for the diagnosis of acute heart failure in the emergency department: A multicenter prospective study.

Buessler A, Chouihed T, Duarte K, Bassand A, Huot-Marchand M, Gottwalles Y, Pénine A, André E, Nace L, Jaeger D, Kobayashi M, Coiro S, Rossignol P, Girerd N

Chest. 2019 Aug 2;:

Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study.

Bitar S, Agrinier N, Alla F, Rossignol P, Mebazaa A, Thilly N

Pharmacoepidemiol Drug Saf. 2019 Jul 24;:

Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views.

Pappaccogli M, Labriola L, Van der Niepen P, Pruijm M, Vogt L, Halimi JM, Ferro CJ, Halabi G, Phan O, Bullani R, Saudan P, Avdelidou A, Panou E, Papoulidou F, London G, Rossignol P, Sarafidis P, Persu A, Wuerzner G

Nephrol. Dial. Transplant.. 2019 Jul 13;:

Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.

Leite S, Cerqueira RJ, Ibarrola J, Fontoura D, Fernández-Celis A, Zannad F, Falcão-Pires I, Paulus WJ, Leite-Moreira AF, Rossignol P, López-Andrés N, Lourenço AP

Circ Heart Fail. 2019 Jul;12(7):e005596

Hyperkalemia in the Emergency Department: Urgent Need for a Rigorous Evaluation of the First-Line Treatments.

Lemoine L, Chouihed T, Legrand M, Rossignol P, Potel G, Montassier E

J Emerg Med. 2019 Jul;57(1):102-103

Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study.

Kobayashi M, Bercker M, Huttin O, Pierre S, Sadoul N, Bozec E, Chouihed T, Ferreira JP, Zannad F, Rossignol P, Girerd N

Int. J. Cardiol.. 2019 Jun 26;:

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Solomon SD, Dickstein K, Atar D, Agewall S, Girerd N,

Am. Heart J.. 2019 Jun 12;215:83-90

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses.

Ferreira JP, Pizard A, Machu JL, Bresso E, Rocca HB, Girerd N, Leroy C, González A, Diez J, Heymans S, Devignes MD, Rossignol P, Zannad F,

Clin Res Cardiol. 2019 May 6;:

Low fibrosis biomarker levels predict cardiac resynchronization therapy response.

Massoullié G, Sapin V, Ploux S, Rossignol P, Mulliez A, Jean F, Marie PY, Merlin C, Pereira B, Andronache M, Motreff P, Chabin X, Sellal JM, Citron B, Lusson JR, Vorilhon C, Clerfond G, Bordachar P, Zannad F, Eschalier R

Sci Rep. 2019 Apr 15;9(1):6103

Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure.

Dobre D, Kjekshus J, Rossignol P, Girerd N, Benetos A, Dickstein K, Zannad F

Int. J. Cardiol.. 2018 Nov 15;271:181-185

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.

Girerd S, Frimat L, Ducloux D, Le Meur Y, Mariat C, Moulin B, Mousson C, Rieu P, Dali-Youcef N, Merckle L, Lepage X, Rossignol P, Girerd N, Jaisser F

Trials. 2018 Oct 30;19(1):595

Stress myocardial perfusion gated-SPECT imaging in advanced chronic kidney disease.

Marie PY, Rossignol P

J Nucl Cardiol. 2018 Oct 22;:

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S

Eur. Heart J.. 2018 Oct 8;:

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial.

Ferreira JP, Barros A, Pitt B, Montalescot G, de Sa EL, Hamm CW, Flather M, Verheugt F, Shi H, Leite-Moreira A, Vincent J, Rossignol P, Zannad F

Clin Res Cardiol. 2018 Sep 27;:

Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.

Rossello X, Ferreira JP, McMurray JJ, Aguilar D, Pfeffer MA, Pitt B, Dickstein K, Girerd N, Rossignol P, Zannad F,

Eur Heart J Acute Cardiovasc Care. 2018 Sep 27;:2048872618803701

Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations.

Covic A, Genovesi S, Rossignol P, Kalra PA, Ortiz A, Banach M, Burlacu A

BMC Med. 2018 Sep 19;16(1):158

Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.

Agarwal R, Rossignol P, Garza D, Mayo MR, Warren S, Arthur S, Romero A, White WB, Williams B

Am. J. Nephrol.. 2018 Sep 3;48(3):172-180

Health-related determinants of undiagnosed arterial hypertension: a population-based study.

Chau K, Girerd N, Zannad F, Rossignol P, Boivin JM

Fam Pract. 2018 Aug 27;:

Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.

Ferreira JP, Rossignol P, Pizard A, Machu JL, Collier T, Girerd N, Huby AC, Gonzalez A, Diez J, López B, Sattar N, Cleland JG, Sever PS, Zannad F

Heart. 2018 Aug 18;:

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N,

Int. J. Cardiol.. 2018 Jul 29;:

Relation of Serum Potassium to Cardiovascular Events in Patients With Heart Failure and Preserved Ejection Fraction: "Mind the Gap".

Pitt B, Rossignol P

Am. J. Hypertens.. 2018 Jul 28;:

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P,

J. Am. Coll. Cardiol.. 2018 Jul 10;72(2):173-182

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.

Ferreira JP, Duarte K, McMurray JJV, Pitt B, van Veldhuisen DJ, Vincent J, Ahmad T, Tromp J, Rossignol P, Zannad F

Circ Heart Fail. 2018 Jul;11(7):e004926

Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort.

Chau K, Girerd N, Bozec E, Ferreira JP, Duarte K, Nazare JA, Laville M, Benetos A, Zannad F, Boivin JM, Rossignol P

J. Hypertens.. 2018 Jun 6;:

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.

Pitt B, Bushinsky DA, Kitzman DW, Ruschitzka F, Metra M, Filippatos G, Rossignol P, Du Mond C, Garza D, Berman L, Lainscak M,

ESC Heart Fail. 2018 Jun;5(3):257-266

Evaluation of Subclinical Fluid Overload Using Lung Ultrasound and Estimated Plasma Volume in the Postoperative Period Following Kidney Transplantation.

Mottola C, Girerd N, Coiro S, Lamiral Z, Rossignol P, Frimat L, Girerd S

Transplant. Proc.. 2018 Jun;50(5):1336-1341

Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings.

Rossignol P, Ferreira JP, Zannad F

Eur. J. Heart Fail.. 2018 May 31;:

A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts.

Ibarrola J, Sádaba R, Garcia-Peña A, Arrieta V, Martinez-Martinez E, Alvarez V, Fernández-Celis A, Gainza A, Santamaría E, Fernández-Irigoyen J, Cachofeiro V, Fay R, Rossignol P, López-Andrés N

Int. J. Cardiol.. 2018 May 1;258:217-223

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF.

Beusekamp JC, Tromp J, van der Wal HH, Anker SD, Cleland JG, Dickstein K, Filippatos G, van der Harst P, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Rossignol P, Zannad F, Voors AA, van der Meer P

Eur. J. Heart Fail.. 2018 May;20(5):923-930

Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).

Frikha Z, Ferreira JP, Bozec E, McMurray JJV, Pitt B, Dickstein K, Rossignol P, Zannad F, Girerd N,

Am. J. Cardiol.. 2018 May 1;121(9):1015-1020

Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.

Chau K, Girerd N, Magnusson M, Lamiral Z, Bozec E, Merckle L, Leosdottir M, Bachus E, Frikha Z, Ferreira JP, Després JP, Rossignol P, Boivin JM, Zannad F

Clin Res Cardiol. 2018 Apr 21;:

Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials.

Ferreira JP, Duarte K, Pitt B, Dickstein K, McMurray JJV, Zannad F, Rossignol P

J. Hypertens.. 2018 Apr 21;:

Galectin-3 downregulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage?

Ibarrola J, Arrieta V, Sádaba R, Martínez-Martínez E, García-Peña A, Alvarez V, Fernández-Celis A, Gainza A, Santamaría E, Fernández-Irigoyen J, Cachofeiro V, Zalba G, Fay R, Rossignol P, López-Andrés N

Clin. Sci.. 2018 Apr 19;:

Impact of the interruption of a large heart failure regional disease management programme on hospital admission rates: a population-based study.

Alla F, Agrinier N, Lavielle M, Rossignol P, Gonthier D, Boivin JM, Zannad F

Eur. J. Heart Fail.. 2018 Apr 16;:

Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.

Van Aelst LNL, Arrigo M, Placido R, Akiyama E, Girerd N, Zannad F, Manivet P, Rossignol P, Badoz M, Sadoune M, Launay JM, Gayat E, Lam CSP, Cohen-Solal A, Mebazaa A, Seronde MF

Eur. J. Heart Fail.. 2018 Apr;20(4):738-747

Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France.

Ferreira JP, Girerd N, Bozec E, Mercklé L, Pizard A, Bouali S, Eby E, Leroy C, Machu JL, Boivin JM, Lamiral Z, Rossignol P, Zannad F

Int J Epidemiol. 2018 Apr 1;47(2):395-395j

Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.

Ferreira JP, Rossignol P, Demissei B, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F

Heart. 2018 Apr;104(7):606-613

Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey.

Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J, Sebbag L, Zannad F, Mebazaa A, Rossignol P,

JACC Heart Fail. 2018 Apr;6(4):273-285

Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair.

Marie PY, Plissonnier D, Bravetti S, Coscas R, Rouer M, Haulon S, Mandry D, Alsac JM, Malikov S, Settembre N, Gouëffic Y, Morel O, Roch V, Micard E, Lamiral Z, Michel JB, Rossignol P

Eur. J. Nucl. Med. Mol. Imaging. 2018 Apr;45(4):549-557

Hyponatraemia, hyperglycaemia and worsening renal function at first blood sample on emergency department admission as predictors of in-hospital death in patients with dyspnoea with suspected acute heart failure: retrospective observational analysis of the

Chouihed T, Buessler A, Bassand A, Jaeger D, Virion JM, Nace L, Barbé F, Salignac S, Rossignol P, Zannad F, Girerd N

BMJ Open. 2018 Mar 30;8(3):e019557

Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.

Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Miró Ò, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E,

Clin Res Cardiol. 2018 Mar;107(3):214-221

Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction

Ferreira JP, Duarte K, Pfeffer MA, McMurray JJV, Pitt B, Dickstein K, Zannad F, Rossignol P,

Eur. J. Heart Fail.. 2018 Feb;20(2):323-331

Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.

Martínez-Martínez E, Ibarrola J, Fernández-Celis A, Calvier L, Leroy C, Cachofeiro V, Rossignol P, López-Andrés N

J. Hypertens.. 2018 Feb;36(2):368-376

Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Coman T, Rossignol J, D'Aveni M, Fabiani B, Dussiot M, Rignault R, Babdor J, Bouillé M, Herbelin A, Coté F, Moura IC, Hermine O, Rubio MT

Oncoimmunology. 2018 ;7(11):e1470735

Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study.

Ferreira JP, Kearney Schwartz A, Watfa G, Zohra L, Felblinger J, Boivin JM, Bracard S, Hossu G, Verger A, Joly L, Zannad F, Rossignol P, Benetos A

J Am Med Dir Assoc. 2017 May 1;18(5):451.e13-451.e25

Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis.

Wagner S, Apetrii M, Massy ZA, Kleber ME, Delgado GE, Scharnagel H, März W, Metzger M, Rossignol P, Jardine A, Holdaas H, Fellström B, Schmieder R, Stengel B, Zannad F,

Free Radic. Res.. 2017 Jan;51(1):14-23

Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Van der Niepen P, Rossignol P, Lengelé JP, Berra E, Sarafidis P, Persu A

Curr. Hypertens. Rep.. 2017 Jan;19(1):5

Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study.

Coiro S, Porot G, Rossignol P, Ambrosio G, Carluccio E, Tritto I, Huttin O, Lemoine S, Sadoul N, Donal E, Zannad F, Girerd N

Sci Rep. 2016 Dec 20;6:39426

A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis.

Girerd N, Ferreira JP, Rossignol P, Zannad F

Eur. J. Heart Fail.. 2016 12;18(12):1411-1414

Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project.

Gargani L, Sicari R, Raciti M, Serasini L, Passera M, Torino C, Letachowicz K, Ekart R, Fliser D, Covic A, Balafa O, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Shavit L, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Kraemer TD, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Onofriescu M, Zarzoulas F, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C

Nephrol. Dial. Transplant.. 2016 12;31(12):1982-1988

Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).

Popovic B, Girerd N, Rossignol P, Agrinier N, Camenzind E, Fay R, Pitt B, Zannad F

Am. J. Cardiol.. 2016 Nov 15;118(10):1442-1447

Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial

Ferreira JP, Girerd N, Pellicori P, Duarte K, Girerd S, Pfeffer MA, McMurray JJ, Pitt B, Dickstein K, Jacobs L, Staessen JA, Butler J, Latini R, Masson S, Mebazaa A, Rocca HP, Delles C, Heymans S, Sattar N, Jukema JW, Cleland JG, Zannad F, Rossignol P,

BMC Med. 2016 Nov 10;14(1):181

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.

Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988

Role for Galectin-3 in Calcific Aortic Valve Stenosis.

Sádaba JR, Martínez-Martínez E, Arrieta V, Álvarez V, Fernández-Celis A, Ibarrola J, Melero A, Rossignol P, Cachofeiro V, López-Andrés N

J Am Heart Assoc. 2016 Nov 4;5(11):

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

Rossignol P, Girerd N, Bakris G, Vardeny O, Claggett B, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Spanyers S, Vincent J, Fay R, Lamiral Z, Solomon SD, Zannad F, Pitt B

Eur. J. Heart Fail.. 2016 Nov;:

Roadmap for cardiovascular prevention trials in chronic kidney disease.

Rossignol P, Pitt B, Thompson A, Zannad F

Lancet. 2016 Oct 22;388(10055):1964-1966

Temporal deformation pattern in acute and late phases of ST-elevation myocardial infarction: incremental value of longitudinal post-systolic strain to assess myocardial viability.

Huttin O, Marie PY, Benichou M, Bozec E, Lemoine S, Mandry D, Juillière Y, Sadoul N, Micard E, Duarte K, Beaumont M, Rossignol P, Girerd N, Selton-Suty C

Clin Res Cardiol. 2016 Oct;105(10):815-26

Temporal Trend and Time-Varying Effect of Preemptive Second Kidney Transplantation on Graft Survival: A 30-Year Single-Center Cohort Study.

Girerd S, Girerd N, Aarnink A, Solimando E, Ladrière M, Kennel A, Rossignol P, Kessler M, Frimat L

Transplant. Proc.. 2016 Oct;48(8):2663-2668

Effectiveness of a multidisciplinary heart failure disease management programme on 1-year mortality: Prospective cohort study.

Laborde-Castérot H, Agrinier N, Zannad F, Mebazaa A, Rossignol P, Girerd N, Alla F, Thilly N

Medicine (Baltimore). 2016 Sep;95(37):e4399

New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.

Zannad F, Rossignol P, Stough WG, Epstein M, Alonso Garcia Mde L, Bakris GL, Butler J, Kosiborod M, Berman L, Mebazaa A, Rasmussen HS, Ruilope LM, Stockbridge N, Thompson A, Wittes J, Pitt B

Int. J. Cardiol.. 2016 Aug 1;216:46-51

Neural modulation for hypertension and heart failure.

Smith S, Rossignol P, Willis S, Zannad F, Mentz R, Pocock S, Bisognano J, Nadim Y, Geller N, Ruble S, Linde C

Int. J. Cardiol.. 2016 Jul 1;214:320-30

Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study).

Ferreira JP, Girerd N, Bozec E, Machu JL, Boivin JM, London GM, Zannad F, Rossignol P

J Am Heart Assoc. 2016 Jun 16;5(6):

Galectin-3 inhibition prevents adipose tissue remodelling in obesity.

Martínez-Martínez E, Calvier L, Rossignol P, Rousseau E, Fernández-Celis A, Jurado-López R, Laville M, Cachofeiro V, López-Andrés N

Int J Obes (Lond). 2016 06;40(6):1034-8

Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C,

Hypertension. 2016 06;67(6):1093-101

Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C,

Hypertension. 2016 06;67(6):1102-10

Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.

Ferreira JP, Girerd N, Medeiros PB, Santos M, Carvalho HC, Bettencourt P, Kénizou D, Butler J, Zannad F, Rossignol P

Clin Res Cardiol. 2016 Jun;105(6):489-507

Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence.

Marie PY, Mandry D, Huttin O, Micard E, Bonnemains L, Girerd N, Beaumont M, Fay R, Joly L, Rossignol P, Benetos A, Felblinger J, Zannad F

J. Hypertens.. 2016 May;34(5):967-73

The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.

Pitt B, Rossignol P

Expert Opin Drug Saf. 2016 May;15(5):659-65

Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging.

Sag AA, Inal I, Okcuoglu J, Rossignol P, Ortiz A, Afsar B, Sos TA, Kanbay M

J Am Soc Hypertens. 2016 Apr;10(4):360-7

Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials.

Sag AA, Sos TA, Benli C, Sal O, Rossignol P, Ortiz A, Solak Y, Kanbay M

J Am Soc Hypertens. 2016 Apr;10(4):368-77

Clinical management of the uraemic syndrome in chronic kidney disease.

Vanholder R, Fouque D, Glorieux G, Heine GH, Kanbay M, Mallamaci F, Massy ZA, Ortiz A, Rossignol P, Wiecek A, Zoccali C, London GM, ,,

Lancet Diabetes Endocrinol. 2016 Apr;4(4):360-73

Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration.

Ferreira JP, Girerd N, Arrigo M, Medeiros PB, Ricardo MB, Almeida T, Rola A, Tolppanen H, Laribi S, Gayat E, Mebazaa A, Mueller C, Zannad F, Rossignol P, Aragão I

Medicine (Baltimore). 2016 Apr;95(14):e3307

[Carotid barostimulation in the treatment of resistant hypertension].

Rossignol P

Nephrol. Ther.. 2016 Apr;12 Suppl 1:S133-4

Left-to-right atrial shunting: new hope for heart failure?

Rossignol P, Zannad F

Lancet. 2016 Mar 26;387(10025):1253-5

Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.

Martinez-Martinez E, Ibarrola J, Calvier L, Fernandez-Celis A, Leroy C, Cachofeiro V, Rossignol P, Lopez-Andres N

PLoS ONE. 2016 ;11(11):e0166272

Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis.

Huttin O, Coiro S, Selton-Suty C, Juillière Y, Donal E, Magne J, Sadoul N, Zannad F, Rossignol P, Girerd N

PLoS ONE. 2016 ;11(12):e0168349

Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!

Girerd N, Zannad F, Rossignol P

Diabetes Metab.. 2015 Dec;41(6):446-55

Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.

Martínez-Martínez E, López-Ándres N, Jurado-López R, Rousseau E, Bartolomé MV, Fernández-Celis A, Rossignol P, Islas F, Antequera A, Prieto S, Luaces M, Cachofeiro V

Hypertension. 2015 Nov;66(5):961-9

Prognostic Value of Estimated Plasma Volume in Heart Failure.

Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P

JACC Heart Fail. 2015 Nov;3(11):886-93

Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.

Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N

Eur. J. Heart Fail.. 2015 Nov;17(11):1172-81

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.

von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P,

Eur. J. Heart Fail.. 2015 Nov;17(11):1144-51

The double challenge of resistant hypertension and chronic kidney disease.

Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D, ,,

Lancet. 2015 Oct 17;386(10003):1588-98

Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.

Martínez-Martínez E, Calvier L, Fernández-Celis A, Rousseau E, Jurado-López R, Rossoni LV, Jaisser F, Zannad F, Rossignol P, Cachofeiro V, López-Andrés N

Hypertension. 2015 Oct;66(4):767-75

Geographic differences in heart failure trials.

Ferreira JP, Girerd N, Rossignol P, Zannad F

Eur. J. Heart Fail.. 2015 Sep;17(9):893-905

Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.

Martínez-Martínez E, Cachofeiro V, Rousseau E, Álvarez V, Calvier L, Fernández-Celis A, Leroy C, Miana M, Jurado-López R, Briones AM, Jaisser F, Zannad F, Rossignol P, López-Andrés N

Mol. Cell. Endocrinol.. 2015 Aug 15;411:20-7

Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians.

Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M

JAMA. 2015 Jul 14;314(2):170-80

Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase.

Urbanet R, Nguyen Dinh Cat A, Feraco A, Venteclef N, El Mogrhabi S, Sierra-Ramos C, Alvarez de la Rosa D, Adler GK, Quilliot D, Rossignol P, Fallo F, Touyz RM, Jaisser F

Hypertension. 2015 Jul;66(1):149-57

Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids.

Tarjus A, Martínez-Martínez E, Amador C, Latouche C, El Moghrabi S, Berger T, Mak TW, Fay R, Farman N, Rossignol P, Zannad F, López-Andrés N, Jaisser F

Hypertension. 2015 Jul;66(1):158-66

Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research.

Zoccali C, Bolignano D, D'Arrigo G, Dekker FW, Fliser D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Parati G, Rossignol P, Tripepi G, Vanholder R, Wiecek A, London G,

Hypertension. 2015 Jul;66(1):3-9

Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism.

Vergaro G, Fatini C, Sticchi E, Vassalle C, Gensini G, Ripoli A, Rossignol P, Passino C, Emdin M, Abbate R

J Cardiovasc Med (Hagerstown). 2015 Jun;16(6):416-22

Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home Residents: The PARTAGE Study.

Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, Salvi P, Zamboni M, Manckoundia P, Hanon O, Gautier S

JAMA Intern Med. 2015 Jun;175(6):989-95

Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial).

Khan SS, Campia U, Chioncel O, Zannad F, Rossignol P, Maggioni AP, Swedberg K, Konstam MA, Senni M, Nodari S, Vaduganathan M, Subacius H, Butler J, Gheorghiade M,

Am. J. Cardiol.. 2015 Mar 15;115(6):790-6

Early and late effects of high- versus low-dose angiotensin receptor blockade on renal function and outcomes in patients with chronic heart failure.

Kiernan MS, Gregory D, Sarnak MJ, Rossignol P, Massaro J, Kociol R, Zannad F, Konstam MA

JACC Heart Fail. 2015 Mar;3(3):214-23

Reproducibility in echocardiographic assessment of diastolic function in a population based study (the STANISLAS Cohort study).

Frikha Z, Girerd N, Huttin O, Courand PY, Bozec E, Olivier A, Lamiral Z, Zannad F, Rossignol P

PLoS ONE. 2015 ;10(4):e0122336

The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.

Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sádaba JR, Zannad F, Rossignol P, López-Andrés N

JACC Heart Fail. 2015 Jan;3(1):59-67

Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries.

Rossignol P, Zannad F, Pitt B,

Int. J. Cardiol.. 2014 Dec 20;177(3):731-3

Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.

Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Dębska-Ślizień A, Fernández Lorente L, Thibaudin D, Franssen C, Schulz M, Moureau F, Loughraieb N, Rossignol P

Kidney Int.. 2014 Dec;86(6):1260-7

Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity.

Mandry D, Eschalier R, Kearney-Schwartz A, Rossignol P, Joly L, Djaballah W, Böhme P, Escanyé JM, Vuissoz PA, Fay R, Zannad F, Marie PY

J. Hypertens.. 2012 Mar;30(3):567-73

Pr ROSSIGNOL Patrick

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Site web

Publications